Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 674
interventional 568
Observational 93
Registry 13

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 204
Drug|placebo 175
Other 44
Biological|placebo 25
Biological 15
Device 14
Drug|Other 13
Device|Drug 11
Dietary Supplement|placebo 10
Dietary Supplement 9
Behavioral 8
Drug|Other|placebo 8
Procedure 5
Other|placebo 4
Device|Other 3
Device|placebo 3
Behavioral|Drug 2
Behavioral|Other 2
Behavioral|Drug|Other 1
Biological|Drug 1
Biological|Drug|placebo 1
Biological|Other|placebo 1
Combination Product|Drug 1
Device|Drug|Other 1
Diagnostic Test 1
Dietary Supplement|Other 1
Drug|Procedure 1
Genetic 1
Other|Procedure 1
placebo 1
Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 173
Germany 47
NA 25
Japan 22
United Kingdom 20
United States|Canada 19
Korea, Republic of 16
Canada 13
France 13
Taiwan 9
Netherlands 8
China 6
Italy 6
Switzerland 6
Finland 5
South Africa 5
Spain 5
Sweden 5
Australia 4
Brazil 4
United States|Canada|Japan 4
Ireland 3
Norway 3
Thailand 3
Austria 2
Belgium 2
Belgium|Germany 2
Canada|Finland|Ireland|Latvia|United Kingdom 2
Denmark 2
Estonia|France|Lithuania|Poland|Romania 2
Germany|Netherlands 2
Israel 2
Mexico 2
Russian Federation 2
United States|Australia|Canada 2
United States|Canada|Puerto Rico 2
United States|Germany|Poland 2
United States|Japan 2
United States|Netherlands 2
Vietnam 2
NA 1
Argentina|Australia|Austria|Brazil|Czechia|France|Germany|Hungary|India|Israel|Japan|Mexico|Poland|Russian Federation|Spain|Switzerland|Taiwan|United Kingdom 1
Argentina|Australia|Austria|Germany|Italy|Japan|Korea, Republic of|Poland|Spain|Taiwan 1
Argentina|Australia|Austria|Hungary|Israel|Japan|Korea, Republic of|Poland|Spain|Switzerland 1
Australia|Austria|Belgium|Bulgaria|Germany|Netherlands|Romania|South Africa 1
Australia|Belgium|Germany|Hungary|Iceland|Malta|Poland|Portugal 1
Australia|Germany|New Zealand 1
Australia|New Zealand 1
Austria|Argentina|Australia|Czechia|Denmark|France|Germany|Hungary|India|Israel|Italy|Japan|Korea, Republic of|Mexico|Poland|Russian Federation|Spain|Switzerland|Taiwan 1
Austria|Belgium|Czech Republic|Denmark|Finland|France|Germany|Italy|Netherlands|Portugal|Spain|Switzerland|United Kingdom 1
Austria|France|Germany 1
Austria|Germany 1
Belgium|Czech Republic|Finland|France|Germany|Hungary|Italy|Netherlands|Portugal|Spain|United Kingdom 1
Belgium|Czechia|France|Germany|Poland|Spain|United Kingdom 1
Belgium|Denmark|Finland|France|Germany|Hungary|Ireland|Latvia|Netherlands|Poland|Spain|United Kingdom 1
Belgium|Germany|Poland|United Kingdom 1
Belgium|Hungary|Moldova, Republic of|Romania 1
Bulgaria|Denmark|Poland 1
Bulgaria|Finland|Germany 1
Canada|Denmark|Finland|United Kingdom 1
Canada|Finland|Germany 1
Canada|Israel 1
Chile 1
China|Philippines 1
Czech Republic 1
Czech Republic|Hungary|Poland 1
Czechia|France|Germany|Hungary|Poland 1
Czechia|United States|Canada|Germany|Hungary|Japan|Poland 1
Dominican Republic 1
Egypt 1
France|Germany|Poland|United Kingdom 1
France|United States|Australia|Canada|Estonia|Korea, Republic of|Latvia|Lithuania|Spain 1
Germany|Czechia|Denmark|France|India|Italy|Japan|Mexico|Russian Federation|Taiwan 1
Germany|France|United States|Australia|Canada|Poland 1
Germany|Hungary|Poland 1
Germany|Poland|Spain|United Kingdom 1
Germany|Spain|Belgium|United States|Canada|Czechia|France|Italy|Japan|Poland|United Kingdom 1
Germany|Switzerland 1
Germany|United States|France|Japan|Spain 1
Hungary 1
Hungary|United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|Chile|China|Czechia|Germany|Israel|Italy|Japan|Korea, Republic of|Latvia|Mexico|Netherlands|Poland|Romania|Russian Federation|Serbia|Slovakia|Spain|Taiwan|United Kingdom 1
India 1
Indonesia 1
Italy|Germany|United States|Bulgaria|Canada|Mexico|Romania|Singapore|Taiwan|Ukraine 1
Japan|Austria|Belgium|Brazil|Finland|France|Germany|Italy|Netherlands|Poland|Russian Federation|Spain|Switzerland|United Kingdom 1
Japan|United States|Australia|Canada|Czechia|Hungary|Italy|Korea, Republic of|Netherlands|New Zealand|Poland|Romania|Spain|United Kingdom 1
Mexico|Venezuela 1
Mongolia 1
Philippines 1
Poland 1
Poland|United Kingdom|Canada|Czech Republic|Germany|Hungary 1
Poland|United States|Australia|Bulgaria|Canada|China|Czechia|Germany|Hungary|Japan|Korea, Republic of|Latvia|United Kingdom 1
Portugal 1
Singapore 1
Spain|United States|Australia|Canada|Czechia|Estonia|Germany|Hungary|Japan|Korea, Republic of|Latvia|Poland|Switzerland|Ukraine|United Kingdom 1
United Kingdom|Austria|Belgium|Germany|Ireland|Netherlands|Poland|Russian Federation|Slovakia|Spain 1
United States|American Samoa|Australia|Austria|Belgium|Bulgaria|Canada|Croatia|Czechia|Denmark|France|Germany|Greece|Hungary|Ireland|Italy|Korea, Republic of|Netherlands|New Zealand|Portugal|Singapore|Spain|Taiwan|United Kingdom 1
United States|Argentina|Australia|Bosnia and Herzegovina|Bulgaria|Canada|China|Colombia|Croatia|Denmark|Estonia|Finland|France|Germany|Italy|Japan|Malaysia|New Zealand|Puerto Rico|Romania|Russian Federation|Switzerland|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Austria|Belgium|Canada|Czechia|Estonia|Finland|France|Germany|Hungary|Iceland|Japan|Netherlands|Poland|Russian Federation|Slovakia|Taiwan|United Kingdom 1
United States|Argentina|Belgium|Brazil|Bulgaria|Canada|Chile|China|Germany|Israel|Italy|Latvia|Mexico|Netherlands|Poland|Romania|Russian Federation|Serbia|Slovakia|Spain|Taiwan 1
United States|Australia 1
United States|Australia|Austria|Belgium|Bulgaria|Canada|China|Czechia|Denmark|Estonia|Finland|France|Germany|Hungary|Ireland|Italy|Japan|Korea, Republic of|Lithuania|Netherlands|New Zealand|Poland|Romania|Russian Federation|Singapore|Slovakia|Spain|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|China|Czechia|France|Germany|Greece|Hong Kong|Hungary|Ireland|Israel|Italy|Japan|Netherlands|New Zealand|Norway|Puerto Rico|Slovakia|Spain|Sweden|United Kingdom 1
United States|Australia|Austria|Canada|China|Spain|Turkey 1
United States|Australia|Austria|Canada|Czechia|Germany|Korea, Republic of|Latvia|Lithuania|Netherlands|New Zealand|Spain|United Kingdom 1
United States|Australia|Belgium|Canada|Finland|Germany|Japan|Netherlands|Spain 1
United States|Australia|Belgium|Canada|France|Germany|Japan|Netherlands|Poland|United Kingdom 1
United States|Australia|Bulgaria|Canada|Chile|Czechia|Germany|Hungary|Italy|Japan|Korea, Republic of|Latvia|Mexico|Poland|Slovakia|Spain|Taiwan|United Kingdom 1
United States|Australia|Bulgaria|Canada|Denmark|Germany|Hungary|Japan|Latvia|Poland 1
United States|Australia|Canada|Croatia|Czechia|Finland|France|Germany|Hungary|Ireland|Israel|Italy|Malaysia|Netherlands|New Zealand|Norway|Poland|Singapore|Spain|Sweden|Taiwan|Ukraine|United Kingdom 1
United States|Australia|Canada|Croatia|Czechia|Finland|France|Germany|Hungary|Ireland|Israel|Italy|Malaysia|Netherlands|New Zealand|Norway|Poland|Singapore|Spain|Taiwan|Ukraine|United Kingdom 1
United States|Australia|Canada|Czechia|Finland|France|Germany|Korea, Republic of|Netherlands|Poland|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Canada|Czechia|Germany|Hungary|Japan|Korea, Republic of|Poland|Spain|United Kingdom 1
United States|Australia|Canada|Czechia|Germany|Hungary|Poland|United Kingdom 1
United States|Australia|Canada|Denmark|Italy|Korea, Republic of|Poland|Russian Federation|United Kingdom 1
United States|Australia|Canada|Germany|Hungary 1
United States|Australia|Canada|Germany|Hungary|New Zealand 1
United States|Australia|Canada|Germany|Japan|Poland 1
United States|Australia|Canada|Japan|Puerto Rico 1
United States|Australia|China|Czechia|Germany|Hungary|Italy|Japan|Latvia|Mexico|Poland|Spain|Taiwan|United Kingdom 1
United States|Australia|China|New Zealand 1
United States|Australia|Germany|Israel|Spain|Switzerland|United Arab Emirates 1
United States|Australia|Germany|Poland|United Kingdom 1
United States|Australia|New Zealand 1
United States|Australia|Poland 1
United States|Austria|Germany|Poland 1
United States|Belgium|Bulgaria|Estonia|France|Germany|Hungary|Italy|Korea, Republic of|Poland|Romania|Singapore 1
United States|Belgium|Canada|Germany|Netherlands|Poland|Spain|United Kingdom 1
United States|Belgium|Czechia|Germany|Korea, Republic of|Poland|Spain 1
United States|Belgium|Germany|Italy|Poland|Sweden|Switzerland|United Kingdom 1
United States|Bulgaria|Canada|Czechia|Germany|Lithuania|Poland 1
United States|Bulgaria|Canada|Czechia|Germany|Poland|Spain 1
United States|Bulgaria|Canada|Denmark|Estonia|Finland|Germany|Japan|Singapore|Spain 1
United States|Canada|Czechia|Germany|Hungary|Poland|United Kingdom 1
United States|Canada|Czechia|Germany|Poland|United Kingdom 1
United States|Canada|Finland|Germany|Iceland|Japan|Netherlands|Poland|Russian Federation|Slovakia|United Kingdom 1
United States|Canada|France|Germany|Hong Kong|Italy|Korea, Republic of|Lithuania|Poland|Sweden|United Kingdom 1
United States|Canada|France|Germany|Hungary|Italy|Poland 1
United States|Canada|Germany 1
United States|Canada|Germany|Japan 1
United States|Canada|South Africa 1
United States|China 1
United States|Dominican Republic|Honduras 1
United States|France|Netherlands 1
United States|Germany 1
United States|Germany|United Kingdom 1
United States|Honduras|Panama 1
United States|Mexico 1
United States|Norway|Puerto Rico 1
United States|Poland 1
United States|Poland|Canada|Czechia|Germany|United Kingdom 1
United States|South Africa 1

Sites per Study

Site_count Study_Count
1 287
2 38
3 21
4 13
5 15
6 9
7 10
8 4
9 6
10 9
11 3
12 6
13 12
14 4
15 5
16 3
17 4
18 2
19 4
20 3
21 1
22 7
23 1
24 1
25 3
26 2
27 4
28 3
29 1
30 1
31 4
32 1
33 1
35 2
36 1
37 1
38 3
40 1
41 1
42 2
43 2
44 1
45 1
47 1
49 1
51 1
52 2
53 1
57 2
58 1
60 4
61 1
63 1
64 1
66 4
67 1
68 1
72 2
73 1
74 1
75 1
76 1
79 1
80 1
81 1
84 2
85 1
87 1
88 1
89 1
90 2
93 2
97 1
101 1
102 1
103 1
114 1
115 2
121 2
123 1
136 1
149 1
153 1
159 1
166 1
181 1
185 1
192 1
196 1
216 1
242 1
289 1
434 1
496 1

Phase

Phase Study_Count
Phase 2 175
N/A 112
Phase 3 102
Phase 4 77
Phase 1 68
Phase 1/Phase 2 24
Early Phase 1 5
Phase 2/Phase 3 5

Number of Arms

Number_of_Arms Count_of_Studies
1 88
2 260
3 82
4 62
5 17
6 12
7 7
8 6
9 2
10 1
11 1
13 2
14 1
27 1
NA 26

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 40.0 6.0000 5.00000 23.00000 5.0000 48.0 20.00 5.0000
1st Qu. 40.0 25.5000 22.75000 36.00000 40.0000 51.0 219.50 30.0000
Median 46.0 52.0000 36.00000 53.00000 90.0000 90.0 371.00 56.0000
Mean 46.4 125.4144 58.13235 56.47826 124.3006 97.8 516.84 107.9041
3rd Qu. 50.0 102.0000 64.00000 67.00000 197.0000 100.0 702.00 120.0000
Max. 56.0 2701.0000 500.00000 145.00000 632.0000 200.0 3000.00 600.0000

Trial Group Type

group_type Group_Count
Experimental 884
Placebo Comparator 294
Active Comparator 204
Other 48
No Intervention 28
NA 26
Sham Comparator 4

Intervention Model

intervention_model Study_Count
Parallel Assignment 400
Single Group Assignment 117
Crossover Assignment 29
Sequential Assignment 13
Factorial Assignment 7
NA 2

Primary Purpose

primary_purpose Study_Count
Treatment 482
Prevention 22
Basic Science 20
Other 14
NA 12
Supportive Care 10
Diagnostic 5
Health Services Research 3

Observational Studies

Studies by Country

Country Study_Count
United States 48
NA 6
Germany 5
Korea, Republic of 4
Canada 3
Austria 2
Denmark 2
Israel 2
Netherlands 2
Poland 2
Switzerland 2
Thailand 2
United Kingdom 2
Chile 1
Finland 1
Hong Kong 1
Indonesia 1
Japan 1
Kazakhstan 1
Lithuania 1
Russian Federation 1
Singapore 1
Taiwan 1
United States|Canada|Chile|Hong Kong|Italy|Netherlands 1

Sites per Study

Site_count Study_Count
1 78
2 8
3 2
4 1
7 2
9 1
14 1

Enrollment Metrics

Measure Observational
Min 9.00
1st Qu 50.00
Median 114.00
Mean 16469.52
3rd Qu 429.50
Max 1027559.00

Observation Model

observational_model Study_Count
Cohort 36
Case-Control 17
Case-Only 13
Case Control 9
NA 9
Other 5
Ecologic or Community 2
Defined Population, Natural History 1
Family-Based 1

Time Perspective

time_perspective Study_Count
Prospective 66
Cross-Sectional 13
Retrospective 9
Other 2
NA 2
Longitudinal, Retrospective 1

Registries

Studies by Country

Country Study_Count
Netherlands 3
United States 2
Austria|Czechia|Taiwan 1
China 1
Germany 1
Korea, Republic of 1
NA 1
United States|Argentina|Australia|Brazil|Canada|Colombia|Denmark|France|Greece|Israel|Italy|Japan|Mexico|Netherlands|Norway|Portugal|Spain 1
United States|Argentina|Brazil|Canada|Colombia|France|Netherlands 1
United States|Canada 1

Sites per Study

Site_count Study_Count
1 6
3 2
7 1
11 1
17 1
38 1
69 1

Enrollment Metrics

Measure Registries
Min 21.00
1st Qu 300.00
Median 600.00
Mean 14991.31
3rd Qu 1200.00
Max 173229.00

Registry Model

observational_model Study_Count
Cohort 9
Case-Only 3
Other 1

Time Perspective

time_perspective Study_Count
Prospective 12
Other 1

Follow-up

target_duration Study_Count
5 Years 5
60 Months 2
10 Years 1
12 Months 1
2 Weeks 1
2 Years 1
3 Years 1
30 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT03823794 Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK) https://ClinicalTrials.gov/show/NCT03823794 Active, not recruiting Momentum Data 2020-05-01
NCT03361215 Disease Trajectories in Atopic Dermatitis and Psoriasis https://ClinicalTrials.gov/show/NCT03361215 Recruiting University of Schleswig-Holstein 2027-01-01
NCT03252340 Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis https://ClinicalTrials.gov/show/NCT03252340 Active, not recruiting EHL Bio Co., Ltd. 2021-08-17
NCT03198390 Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions https://ClinicalTrials.gov/show/NCT03198390 Recruiting University of Arizona 2020-07-01
NCT03168113 Atopic Dermatitis (AD) and Food Allergy https://ClinicalTrials.gov/show/NCT03168113 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2018-01-31
NCT03142139 Does Timeliness of DTaP-IPV-Hib Vaccination Affect Development of Atopic Dermatitis Before 1 Year of Age? https://ClinicalTrials.gov/show/NCT03142139 Completed Bandim Health Project 2014-12-31
NCT03112876 Sebum Collection and Skin Barrier Function Analysis https://ClinicalTrials.gov/show/NCT03112876 Completed University of California, Davis 2016-02-26
NCT03050658 Bathing Babies and Allergy https://ClinicalTrials.gov/show/NCT03050658 Recruiting University of Virginia 2018-01-01
NCT03003793 Insulin Sensitivity in Patients With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT03003793 Completed University Hospital, Gentofte, Copenhagen 2016-09-30
NCT02926807 Trial on Vascular Inflammation in Atopic Dermatitis https://ClinicalTrials.gov/show/NCT02926807 Completed Innovaderm Research Inc. 2018-11-30
NCT02916888 A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists https://ClinicalTrials.gov/show/NCT02916888 Completed Yale University 2017-12-31
NCT02910791 The Role of Bacterial Toxins in Human Skin Disease https://ClinicalTrials.gov/show/NCT02910791 Recruiting National Jewish Health 2022-12-31
NCT02866864 Animal Allergy in Korean Veterinary Researcher https://ClinicalTrials.gov/show/NCT02866864 Completed Gachon University Gil Medical Center 2016-08-26
NCT02680405 Identification of Epidermal Signatures in Patients With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT02680405 Active, not recruiting National Jewish Health 2016-07-31
NCT00605878 Studies of Skin Microbes in Healthy People and in People With Skin Conditions https://ClinicalTrials.gov/show/NCT00605878 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02552979 Atopy Patch Test in Children With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT02552979 Completed Mahidol University 2014-12-31
NCT02532920 The Natural History of Atopic Disease in Thai Children and Association With Atopic March https://ClinicalTrials.gov/show/NCT02532920 Completed Mahidol University 2016-06-30
NCT01686048 The Significance of Ambrosia in Allergic Rhinitis and Asthma in Israel https://ClinicalTrials.gov/show/NCT01686048 Completed Meir Medical Center 2015-04-30
NCT02401178 The Role of Filaggrin and FADS Genes on the Concentrations of PUFA Towards Its Effect on Atopic Dermatitis in Infants https://ClinicalTrials.gov/show/NCT02401178 Completed Indonesia University 2015-12-31
NCT02270411 Inflammatory Cells From Various Pathologies https://ClinicalTrials.gov/show/NCT02270411 Recruiting Innovaderm Research Inc. 2021-12-31
NCT02125695 Pilot Tape Harvesting Study https://ClinicalTrials.gov/show/NCT02125695 Completed Biogen 2016-08-31
NCT02115399 ADRN Barrier/Immunoprofiling Exploratory Pilot Study https://ClinicalTrials.gov/show/NCT02115399 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2015-03-31
NCT02098551 Skin Testing With Recombinant Bet v 1 and Hypoallergenic Recombinant Bet v 1 Fragments https://ClinicalTrials.gov/show/NCT02098551 Completed Medical University of Vienna 2011-11-30
NCT02091037 S. Aureus Colonization in Atopic Dermatitis https://ClinicalTrials.gov/show/NCT02091037 Active, not recruiting Columbia University 2016-12-31
NCT02073591 Correlation Study Between PEST and SCORAD in Management of Atopic Dermatitis With Ceradan® Regimen https://ClinicalTrials.gov/show/NCT02073591 Completed Hyphens Pharma Pte Ltd 2014-11-30
NCT03358693 Anti-cytokine Signatures in Inflammatory Skin Disease https://ClinicalTrials.gov/show/NCT03358693 Recruiting University of Schleswig-Holstein 2024-12-31
NCT01995747 The Effect of Anti-CεmX on IgE Production https://ClinicalTrials.gov/show/NCT01995747 Completed National Taiwan University Hospital 2012-06-30
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions https://ClinicalTrials.gov/show/NCT01931644 Recruiting Sanguine Biosciences 2025-08-31
NCT01920464 Place of Flixovate® in the Treatment Pathway and Its Conditions of Use in Infants Aged From 3 to 12 Months Between 2010 and 2012 by French GPs and Private Paediatricians https://ClinicalTrials.gov/show/NCT01920464 Completed GlaxoSmithKline 2013-10-31
NCT01897506 Assessing Risk of Food Insecurity Within Households of Children With Food Allergy https://ClinicalTrials.gov/show/NCT01897506 Completed Arkansas Children’s Hospital Research Institute 2015-12-31
NCT01861548 Polish Mother and Child Cohort Study (REPRO_PL) - Follow up of the Children. https://ClinicalTrials.gov/show/NCT01861548 Completed Medical Universtity of Lodz 2013-05-31
NCT01854580 Evaluation of an Integrated Care Project https://ClinicalTrials.gov/show/NCT01854580 Completed Charite University, Berlin, Germany 2018-12-31
NCT01789619 Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis Patients https://ClinicalTrials.gov/show/NCT01789619 Completed UMC Utrecht 2014-01-31
NCT01782703 Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis https://ClinicalTrials.gov/show/NCT01782703 Recruiting Northwestern University 2020-12-31
NCT01714245 A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients https://ClinicalTrials.gov/show/NCT01714245 Completed TopMD Skin Care, Inc. 2013-12-31
NCT01569906 Narrowband UVB for Children With Moderate to Severe Atopic Eczema https://ClinicalTrials.gov/show/NCT01569906 Completed Royal Victoria Infirmary 2010-08-31
NCT01494142 Registry for the Atopic Dermatitis Research Network https://ClinicalTrials.gov/show/NCT01494142 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2018-02-07
NCT01489293 Inhibitory Receptors in Eosinophils of Atopic Subjects https://ClinicalTrials.gov/show/NCT01489293 Completed Meir Medical Center 2013-12-31
NCT01447381 Systemic Therapies for Pediatric Atopic Dermatitis https://ClinicalTrials.gov/show/NCT01447381 Recruiting Rady Children’s Hospital, San Diego 2021-07-31
NCT01429311 Interferon Responses in Eczema Herpeticum https://ClinicalTrials.gov/show/NCT01429311 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2016-01-31
NCT01356758 Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents https://ClinicalTrials.gov/show/NCT01356758 Completed University of Aarhus 2015-09-30
NCT04440410 Evaluation of Cutaneous and Circulating Inflammatory Biomarkers in Hidradenitis Suppurativa and Atopic Dermatitis https://ClinicalTrials.gov/show/NCT04440410 Recruiting Kymera Therapeutics, Inc. 2020-08-31
NCT04362852 Patient Forward Access to Clinical and Technological Research: Genetic Influences on Lung Cancer and Atopic Dermatitis https://ClinicalTrials.gov/show/NCT04362852 Recruiting Boston Children’s Hospital 2021-02-01
NCT04354207 Vitamin D and Its Receptor Gene Polymorphisms in Lithuanian, Latvian and Taiwanese Patients With Atopic Dermatitis and Asthma https://ClinicalTrials.gov/show/NCT04354207 Enrolling by invitation Lithuanian University of Health Sciences 2022-08-01
NCT04276623 Identifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab Treatment https://ClinicalTrials.gov/show/NCT04276623 Recruiting UMC Utrecht 2022-09-01
NCT04240522 Prospective Longitudinal Observational Research in Atopic Dermatitis https://ClinicalTrials.gov/show/NCT04240522 Recruiting University of Zurich 2020-01-20
NCT04218877 The Factors Affecting Atopic Dermatitis in Children Age 1-3 https://ClinicalTrials.gov/show/NCT04218877 Recruiting Akusherstvo Pro 2020-07-10
NCT04186949 Early Origins of Allergy and Asthma https://ClinicalTrials.gov/show/NCT04186949 Active, not recruiting Pontificia Universidad Catolica de Chile 2022-12-31
NCT04180644 Skin Tape Transcriptome Methods in Children https://ClinicalTrials.gov/show/NCT04180644 Completed National Jewish Health 2020-02-05
NCT04173442 Post-authorization Safety Study in North America to Monitor Pregnancy and Infant Outcomes Following Administration of Dupilumab During Planned or Unexpected Pregnancy https://ClinicalTrials.gov/show/NCT04173442 Recruiting Regeneron Pharmaceuticals 2026-01-09
NCT04154839 Epidemiological Survey and Genetic Analysis of AD Patients in Hong Kong https://ClinicalTrials.gov/show/NCT04154839 Recruiting The University of Hong Kong 2021-12-31
NCT04097327 Effect of Ectoin Dermatitis Cream 7% on Skin Hydration and Skin Barrier Function https://ClinicalTrials.gov/show/NCT04097327 Completed Bitop AG 2019-12-31
NCT04087863 Administration for Placebo Group and Evalution the Safety and Efficacy in Atopic Dermatitis Patients https://ClinicalTrials.gov/show/NCT04087863 Recruiting Kang Stem Biotech Co., Ltd. 2022-12-31
NCT04060550 Impact of Increased Immunoglobulin E to Anti-herpes Simplex Virus -1 Innate Immune Responses in Atopic Dermatitis Patients With Eczema Herpeticum https://ClinicalTrials.gov/show/NCT04060550 Recruiting National Jewish Health 2020-09-01
NCT04008784 Improvement of Short Term Outcome of Mild to Moderate Atopic Dermatitis Using a Combination of Crisaborole and a Concomitant Topical Corticosteroid Over a 8 Week Period https://ClinicalTrials.gov/show/NCT04008784 Recruiting Clinical Research Center of the Carolinas 2020-02-29
NCT03962387 Evalution the Safety and Efficacy in Atopic Dermatitis Patients https://ClinicalTrials.gov/show/NCT03962387 Recruiting Kang Stem Biotech Co., Ltd. 2024-01-02
NCT03936335 Dupilumab and Pregnancy Outcomes: A Retrospective Cohort Study Using Administrative Healthcare Databases (Dupi PODS) https://ClinicalTrials.gov/show/NCT03936335 Recruiting Regeneron Pharmaceuticals 2027-07-21
NCT03831646 Clinical, Psychological and Genetic Characteristics in Dermatological Patients https://ClinicalTrials.gov/show/NCT03831646 Completed Astana Medical University 2019-07-10
NCT03813472 Hydration Sensor for Atopic Dermatitis https://ClinicalTrials.gov/show/NCT03813472 Enrolling by invitation Northwestern University 2021-04-30
NCT03800004 Bone Health in Patients With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT03800004 Recruiting Mayo Clinic 2020-12-30
NCT03770858 Wearable Skin Sensors to Assess Nocturnal Scratch Behavior https://ClinicalTrials.gov/show/NCT03770858 Recruiting Northwestern University 2021-09-30
NCT03581747 Detection of Skin Epithelial Barrier in Patients With Allergic Skin Disorders https://ClinicalTrials.gov/show/NCT03581747 Recruiting Swiss Institute of Allergy and Asthma Research 2019-12-31
NCT03559075 Clinical vs. Anecdotal Evidence - Pediatric Atopic Dermatitis https://ClinicalTrials.gov/show/NCT03559075 Completed Wake Forest University Health Sciences 2018-08-08
NCT03490877 Scratch and Sleep Quantification in Atopic Dermatitis https://ClinicalTrials.gov/show/NCT03490877 Completed University of Rochester 2019-04-30
NCT03411837 Dupilumab Phase 4 Study https://ClinicalTrials.gov/show/NCT03411837 Enrolling by invitation Northwestern University 2020-03-31
NCT01238263 Autologous Serum Skin Testing in Patients With Atopic Dermatitis Autologous Serum Skin Testing in Patients With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT01238263 Completed Yuzuncu Yıl University 2010-06-30
NCT01164241 Natural History of Diseases Associated With Allergic Inflammation: Atopic Dermatitis and Genetic and Congenital Diseases Associated With Atopic Pathways https://ClinicalTrials.gov/show/NCT01164241 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT01069666 Knowledge Base in the Treatment of Atopic Dermatitis Among Thai Pediatricians https://ClinicalTrials.gov/show/NCT01069666 Completed Siriraj Hospital NA
NCT00879944 Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index https://ClinicalTrials.gov/show/NCT00879944 Completed Northwestern University 2012-06-30
NCT00822276 The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA) https://ClinicalTrials.gov/show/NCT00822276 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2009-11-30
NCT03874039 Sweat and Gas Sensor for Healthy Skin and Atopic Dermatitis https://ClinicalTrials.gov/show/NCT03874039 Recruiting Northwestern University 2020-12-31
NCT00815984 Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic Diseases https://ClinicalTrials.gov/show/NCT00815984 Completed Medical Universtity of Lodz 2010-01-31
NCT00006150 Study of Clinical Features and Genetics of Hyperimmunoglobulin E Recurrent Infection https://ClinicalTrials.gov/show/NCT00006150 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02627989 An Observational Study Investigating the Treatment Satisfaction of Atopic Dermatitis Patients Who Have Switched to Ointment (W/O Emulsion) Formulation of Very Strong Class Topical Corticosteroids https://ClinicalTrials.gov/show/NCT02627989 Completed LEO Pharma 2016-11-17
NCT00696397 Comprehensive Investigation of Opiates, Neuropeptides, Barrier Function, Scratching and Sleep Physiology https://ClinicalTrials.gov/show/NCT00696397 Completed Wake Forest University Health Sciences 2009-12-31
NCT00691366 Comprehensive Investigation of Heart Rate Variability as a Measure of the Autonomic Nervous System in Atopic Dermatitis https://ClinicalTrials.gov/show/NCT00691366 Completed Wake Forest University Health Sciences 2009-12-31
NCT00660127 The Effect of Visual Stimuli on Itch Perception Intensity in Healthy and Atopic Dermatitis Patients https://ClinicalTrials.gov/show/NCT00660127 Completed Wake Forest University Health Sciences 2009-12-31
NCT00568997 10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus https://ClinicalTrials.gov/show/NCT00568997 Recruiting Bausch Health Americas, Inc. 2026-12-31
NCT00555178 Regulatory T Cells (Tregs) in Polymorphic Light Eruption https://ClinicalTrials.gov/show/NCT00555178 Completed Medical University of Graz 2014-12-31
NCT00515047 Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT00515047 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2011-01-31
NCT00459576 Risk of Asthma in Infants With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT00459576 Completed Indiana University 2012-01-31
NCT00438022 Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT00438022 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2010-01-31
NCT00407979 Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis https://ClinicalTrials.gov/show/NCT00407979 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2009-02-28
NCT00407069 Role of Antimicrobial Peptides in Host Defense Against Vaccinia Virus https://ClinicalTrials.gov/show/NCT00407069 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2010-02-28
NCT00406081 Immune Response to Varicella Vaccination in Children With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT00406081 Completed National Institute of Allergy and Infectious Diseases (NIAID) 2009-09-30
NCT00379678 Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT00379678 Completed National Jewish Health 2007-03-31
NCT00371163 Molecular and Cellular Characterization of Spongiotic Dermatitis https://ClinicalTrials.gov/show/NCT00371163 Completed University of California, Davis 2012-12-31
NCT00277433 Histamine Pharmacogenetics in Children With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT00277433 Completed Virginia Commonwealth University 2009-12-31
NCT00177268 Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research https://ClinicalTrials.gov/show/NCT00177268 Recruiting University of Pittsburgh 2027-01-31
NCT00167752 Psychiatric Problems in Chronic Skin Diseases https://ClinicalTrials.gov/show/NCT00167752 Completed University of Wisconsin, Madison 2006-02-28
NCT00098150 Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis https://ClinicalTrials.gov/show/NCT00098150 Completed Novartis NA
NCT00795496 Bronchial Hyperreactivity in Atopic Dermatitis Patients - a 10 Year Follow-up https://ClinicalTrials.gov/show/NCT00795496 Completed University of Helsinki 2010-04-30
NCT00001760 Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals https://ClinicalTrials.gov/show/NCT00001760 Completed National Institutes of Health Clinical Center (CC) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT04462055 Effectiveness of Dupilumab in Food Allergic Patients With Moderate to Severe Atopic Dermatitis https://ClinicalTrials.gov/show/NCT04462055 Recruiting UMC Utrecht 2022-07-01
NCT03661866 A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for IMISC https://ClinicalTrials.gov/show/NCT03661866 Recruiting Target PharmaSolutions, Inc. 2026-10-31
NCT03253666 Nurses’ Health Study and Health Professionals Follow-Up Study (Dermatological Component) https://ClinicalTrials.gov/show/NCT03253666 Enrolling by invitation Harvard School of Public Health 2020-12-31
NCT03057860 TREATgermany: German National Clinical Registry for Patients With Moderate-to-severe Atopic Dermatitis https://ClinicalTrials.gov/show/NCT03057860 Recruiting Technische Universität Dresden 2021-01-31
NCT02889081 Maternal Key Nutritional Factors and Offspring’s Atopic Dermatitis (MKNFOAD) https://ClinicalTrials.gov/show/NCT02889081 Completed Children’s Hospital of Fudan University 2017-10-31
NCT02126176 Protopic Adherence and Efficacy in Korean Eczema Patient https://ClinicalTrials.gov/show/NCT02126176 Completed Pusan National University Hospital 2016-03-31
NCT04017520 Breast Milk: Influence of the Micro-transcriptome Profile on Atopy in Children and Toddlers https://ClinicalTrials.gov/show/NCT04017520 Recruiting Milton S. Hershey Medical Center 2021-04-30
NCT03992417 Observational Study of Adult Patients Receiving Dupixent® for Atopic Dermatitis (AD) https://ClinicalTrials.gov/show/NCT03992417 Recruiting Sanofi 2026-04-30
NCT03849716 Evaluation of Biomarkers of Atopic Dermatitis in Pediatric Patients (PEDISTAD BIOMARKER STUDY) https://ClinicalTrials.gov/show/NCT03849716 Recruiting Sanofi 2025-12-31
NCT03687359 Observational Evaluation of Atopic Dermatitis in Pediatric Patients https://ClinicalTrials.gov/show/NCT03687359 Recruiting Sanofi 2025-12-31
NCT03621137 TREAT NL (TREatment of ATopic Eczema, the Netherlands) Registry: Dutch National Registry for Patients With Moderate-to-severe Atopic Eczema on Photo- or Systemic Therapies https://ClinicalTrials.gov/show/NCT03621137 Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2027-10-31
NCT03549416 BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients With Atopic Dermatitis https://ClinicalTrials.gov/show/NCT03549416 Recruiting UMC Utrecht 2028-12-31
NCT03428646 Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD) https://ClinicalTrials.gov/show/NCT03428646 Recruiting Regeneron Pharmaceuticals 2025-12-31